In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Legend Biotech (LEGN – Research Report).

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

The S&P 500 rallied in the wake of last week's election results, climbing 3.8% since Nov. 5 at Wednesday's prices. But not ...

We recommend buying CNYA ETF for its diversification, despite high expense ratio and valuation concerns. Read here for an ...

Biotech stocks can be incredibly attractive for risk-taking investors because of their ability to go parabolic in an instant.

Headquartered in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a biotechnology company specializing in messenger RNA ...

OmniAb, Inc, a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens ...

Invest in SLYG ETF for exposure to small-cap U.S. companies with growth potential, diversified portfolio, and attractive ...

Biotechs have underperformed the broader market this year, and these stock are at crossroads as they await the new ...